Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» Blincyto
Blincyto
Will Blincyto's Expanded FDA Approval Open the Door for Wider Use of MRD as a Biomarker or Endpoint?
Will Blincyto's Expanded FDA Approval Open the Door for Wider Use of MRD as a Biomarker or Endpoint?
RAPS.org
Amgen
Blincyto
ALL
B-cell precursor ALL
Flag link:
Two cancer drug prices have already been hiked by 8% this year
Two cancer drug prices have already been hiked by 8% this year
Marketwatch
drug pricing
cancer
Amgen
Blincyto
Teva Pharmaceutical
Treanda
lymphoma
leukemia
Flag link:
FDA Grants Priority Review For Amgen's BLINCYTO® (blinatumomab) Supplemental Biologics License Application
FDA Grants Priority Review For Amgen's BLINCYTO® (blinatumomab) Supplemental Biologics License Application
Yahoo
Amgen
FDA
priority review
Blincyto
acute lymphoblastic leukemia
Flag link:
Get Ready For Amgen's PDUFA Date For BLINCYTO On September 1
Get Ready For Amgen's PDUFA Date For BLINCYTO On September 1
Seeking Alpha
Amgen
Blincyto
acute lymphoblastic leukemia
Flag link:
Amgen and Merck & Co to Collaborate for Immunotherapy Cancer
Amgen and Merck & Co to Collaborate for Immunotherapy Cancer
Bidness, ETC
Amgen
Merck
Keytruda
cancer immunotherapy
Blincyto
Flag link:
5 Key Drugs That Just Won EU Endorsements
5 Key Drugs That Just Won EU Endorsements
Investors.com
Europe
Gilead Sciences
Genvoya
Amgen
Kyprolis
Blincyto
Vertex Pharmaceuticals
Orkambi
Horizon Pharma
Ravicti
Flag link:
Amgen's leukemia drug gets conditional European approval
Amgen's leukemia drug gets conditional European approval
Yahoo/Reuters
Amgen
Europe
Blincyto
acute lymphoblastic leukemia
Flag link:
Dr. Reddy’s Announces Strategic Collaboration with Amgen in India
Dr. Reddy’s Announces Strategic Collaboration with Amgen in India
Yahoo
Dr Reddy's
Amgen
India
Kyprolis
Blincyto
Repatha
Flag link:
Amgen reports positive preliminary results on leukemia drug
Amgen reports positive preliminary results on leukemia drug
Yahoo/Reuters
Amgen
Blincyto
acute lymphoblastic leukemia
Flag link:
Amgen Dazzles With a Duo of Fresh Data
Amgen Dazzles With a Duo of Fresh Data
Investopedia
Amgen
Blincyto
Vectibix
AMG 334
Flag link:
Amgen slaps record-breaking $178K price on rare leukemia drug Blincyto
Amgen slaps record-breaking $178K price on rare leukemia drug Blincyto
Fierce Pharma Marketing
Amgen
Blincyto
acute lymphoblastic leukemia
Flag link:
Amgen Leukemia Therapy Costs $178,000, Among Priciest Drugs
Amgen Leukemia Therapy Costs $178,000, Among Priciest Drugs
Bloomberg
drug pricing
Amgen
Blincyto
acute lymphoblastic leukemia
Flag link:
Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease
Amgen Announces New Data From Phase 2 BLINCYTO™ (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease
Yahoo/PR Newswire
Amgen
Blincyto
acute lymphoblastic leukemia
leukemia
Flag link:
Amgen's Blincyto Gets FDA Nod, Carries Boxed Warning
Amgen's Blincyto Gets FDA Nod, Carries Boxed Warning
Yahoo/Zacks.com
Amgen
Blincyto
FDA
warnings
acute lymphoblastic leukemia
Flag link:
FDA approves Amgen immunotherapy drug Blincyto for rare form of leukemia
FDA approves Amgen immunotherapy drug Blincyto for rare form of leukemia
Yahoo/AP
FDA
Amgen
Blincyto
B-cell acute lymphoblastic leukemia
Flag link: